Total Health
C

Genetic Testing and Management of Breast Cancer Susceptibility - Germline Mutations

By Total Health FEATURING Claudine Isaacs
By Total Health FEATURING Claudine Isaacs
142 views
February 29, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

03:15
Lilly Medical Affairs

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh

Recommended

07:23

Advanced Stage HR+ BC: Fine-Tuning Sequential Endocrine and Targeted…

Total Health

R. O'Regan

1.3K views

·

8 months ago
09:19

SABCS 2023 Insights: "Biology or Stage? Tailoring Treatment for Prem…

Insights from 2023 SABCS

K. Kalinsky

1.8K views

·

11 months ago
33:44

ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clini…

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

919 views

·

4 months ago
09:10

Brief Update on Genomic Assays for Early Stage Breast Cancer

Adam Brufsky

417 views

·

2 months ago
23:17

Clinical Applications of ctDNA in Breast Cancer Diagnosis and Manage…

University of Miami Sylvester Comprehensive Cancer Center

D. Tripathy

618 views

·

3 months ago
11:13

ASCO® 2024 Insights: "Development and Validation of RSClinN+ Tool fo…

2024 ASCO® Annual Meeting Insights Hub

L. Pusztai

784 views

·

5 months ago
11:07

ASCO® 2024 Insights: "Ultra-Sensitive ctDNA Mutation Tracking to Ide…

2024 ASCO® Annual Meeting Insights Hub

I. Garcia-Murillas

700 views

·

5 months ago
16:57

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

678 views

·

5 months ago
15:52

Managing Metastatic Breast Cancer: Case Study Insights

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

N. Hunter

369 views

·

3 months ago
25:35

NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing

Total Health

S. Kazmi

4.3K views

·

2 years ago
07:25

ESMO 2024 Insights: DESTINY-Breast04 - Exploratory Biomarker Analysi…

2024 ESMO Annual Meeting Insights Hub

N. Ueno

232 views

·

1 month ago
25:45

Identifying Breast Cancer Subtypes and Recurrence Risk: Multigene As…

Han-Byoel Lee

314 views

·

2 months ago
19:17

Inflammatory Breast Cancer - Diagnosis and Management Updates

Weill Cornell Medicine Oncology & Hematology

M. Cristofanilli

496 views

·

6 months ago
12:37

Young Women With HR+/HER2- Breast Cancer: Options for Risk Assessment

University of Colorado Cancer Center

V. Borges

426 views

·

6 months ago
27:15

ASCO® 2024 Summary: "Management of Higher Risk eBC Including BRCAm, …

2024 ASCO® Annual Meeting Insights Hub

M. Dolezal

350 views

·

4 months ago
08:48

2L Therapy for ER+ mBC Following CDK4/6i

James Martin

500 views

·

10 months ago
14:45

ASCO® 2024 Insights: "Elucidating the Immune Active State of HR+/HER…

2024 ASCO® Annual Meeting Insights Hub

E. Cobain

353 views

·

5 months ago
15:49

New

New Frontiers in Oncology: Advanced Diagnostics and Therapeutics

Springer Healthcare IME

S. Peters

163 views

·

3 weeks ago
26:55

Understanding ESR1 Mutations in HR+/HER2- mBC: Testing Methods, Pati…

Massachusetts General Hospital Cancer Center

S. Wander

316 views

·

3 months ago
07:34

Summary of the Updated Results of SOFT/TEXT Trials and the Meta-Anal…

PrecisCa

M. Pegram

894 views

·

1 year ago
AUTOPLAY